2,8-dibromodibenzofuran | CAS:10016-52-1

We serve 2,8-dibromodibenzofuran CAS:10016-52-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2,8-dibromodibenzofuran

Chemical Name:2,8-dibromodibenzofuran
CAS.NO:10016-52-1
Synonyms:2,8-dibromo dibeozofuran
3,6-dibromooxygafluorene
2,8-dibromo-dibenzofuran
2,8-Dibromodibenzo[b,d]furan
Molecular Formula:C12H6Br2O
Molecular Weight:325.98300
 
Physical and Chemical Properties:
Density:1.886
Boiling point:396ºC
Flash point:193.3ºC
Index of Refraction:1.738
 
Specification:
Appearance:Off-white powder
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates



Contact us for information like 2,8-dibromodibenzofuran chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,8-Dibromodibenzo[b,d]furan physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,8-dibromo-dibenzofuran Use and application,2,8-Dibromodibenzo[b,d]furan technical grade,usp/ep/jp grade.


Related News: The term active pharmaceutical ingredient may refer to an active chemical within an FDA-regulated drug, or API might mean the entire drug with its active and inactive ingredients.2-Chloropropionic acid manufacturer “Administrative Measures for the Joint Review, Review and Approval of Raw Materials, Medicinal Auxiliaries and Pharmaceutical Packaging Materials and Pharmaceutical Preparations” (Consultation Draft) issued by the State Food and Drug Administration in December 2017. Supervision departments no longer accept applications for registration of APIs, pharmaceutical excipients, and packaging materials.2-Bromophenanthrene supplier “Administrative Measures for the Joint Review, Review and Approval of Raw Materials, Medicinal Auxiliaries and Pharmaceutical Packaging Materials and Pharmaceutical Preparations” (Consultation Draft) issued by the State Food and Drug Administration in December 2017. Supervision departments no longer accept applications for registration of APIs, pharmaceutical excipients, and packaging materials.1,4-difluorobenzene vendor Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System.With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines.